Clene Inc. has announced the termination of its previously unsold common stock offering under its at-the-market (ATM) equity distribution agreement. The offering, which was initially set to offer and sell $15,000,000 worth of shares, was later reduced to $12,300,000. As of the latest update, Clene Inc. had sold approximately $2,098,857 in shares, leaving an unsold amount of roughly $12,901,143. The termination of the offering of these unsold shares is effective as of September 30, 2024, as stated in Supplement No. 2 to the Prospectus Supplement. Despite this termination, the ATM Agreement with Canaccord Genuity LLC, which was entered into on April 14, 2022, remains in effect. This move follows the company's previous filings, including the Prospectus Supplement dated November 7, 2023, and Supplement No. 1 dated May 8, 2024, in conjunction with the base prospectus dated April 26, 2022.

Clene Inc. has announced the termination of its previously unsold common stock offering under its at-the-market (ATM) equity distribution agreement. The offering, which was initially set to offer and sell $15,000,000 worth of shares, was later reduced to $12,300,000. As of the latest update, Clene Inc. had sold approximately $2,098,857 in shares, leaving an unsold amount of roughly $12,901,143. The termination of the offering of these unsold shares is effective as of September 30, 2024, as stated in Supplement No. 2 to the Prospectus Supplement. Despite this termination, the ATM Agreement with Canaccord Genuity LLC, which was entered into on April 14, 2022, remains in effect. This move follows the company's previous filings, including the Prospectus Supplement dated November 7, 2023, and Supplement No. 1 dated May 8, 2024, in conjunction with the base prospectus dated April 26, 2022.